Both in Pharmaceuticals
Pliant Therapeutics vs iBio
Over the past year PLRX returned −47.1% and IBIO returned −47.7%; their daily moves had a correlation of 0.20.
PLRX −47.1% IBIO −47.7%Growth of $1, one year, split-adjusted
| Metric | PLRX | IBIO |
|---|---|---|
| Price | $0.8518 | $0.8000 |
| Market cap | $52.7M | $51.4M |
| Today | −1.03% | −2.85% |
| 1 month | −17.3% | −23.8% |
| 6 months | −30.7% | −54.8% |
| Year to date | −30.2% | −58.5% |
| 1 year | −49.0% | −54.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 514.5× |
| Net cash | $158.1M | $88.0M |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 65.6% |
| Short % of float | 9.6% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).